Inhibitory effect of ascorbic acid (vitamin C) on cortisol secretion following adrenal stimulation in children

Insights

High-dose ascorbic acid (AA) significantly lowers cortisol levels after adrenocorticotropic hormone (ACTH) stimulation in children. This suggests excess AA may inhibit cortisol secretion, potentially offering no benefit during stress.

Area of Science:

  • Endocrinology
  • Nutritional Science

Background:

  • Ascorbic acid (AA), also known as vitamin C, plays a role in various physiological processes.
  • The interaction between AA and the hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol secretion, is not fully understood.

Purpose of the Study:

  • To investigate the effect of high-dose ascorbic acid administration on plasma cortisol levels following adrenocorticotropic hormone (ACTH) stimulation in healthy children.

Main Methods:

  • Plasma cortisol levels were measured in two groups of healthy children before and after intramuscular ACTH administration.
  • Group B received oral ascorbic acid (1 g t.i.d.) for five days, while Group A did not receive AA.
  • Cortisol levels were compared between groups and within Group B before and during AA administration.

Main Results:

  • On the fifth day of AA administration, mean cortisol values after ACTH stimulation in Group B were significantly lower compared to Group A (p < 0.02).
  • Post-ACTH cortisol levels in Group B during AA administration were also significantly lower than those observed before AA treatment (p < 0.001).
  • Ascorbic acid administration did not significantly affect fasting plasma cortisol levels.

Conclusions:

  • Excessive ascorbic acid intake appears to exert an inhibitory effect on cortisol secretion in response to ACTH stimulation.
  • These findings suggest that high-dose AA may not be beneficial in managing conditions involving physiological stress, where adequate cortisol response is crucial.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...